Fetomaternal outcomes of hyperlipidemia in pregnancy
DOI:
https://doi.org/10.18203/2320-1770.ijrcog20260891Keywords:
Hyperlipidemia, Neonatal outcomes, Pregnancy, Lipid profile, Maternal outcomes, PreeclampsiaAbstract
Background: Maternal lipid levels increase physiologically during pregnancy; however, excessive elevations may be associated with adverse maternal and neonatal outcomes. This study aimed to evaluate maternal lipid profile patterns and their association with fetomaternal outcomes.
Methods: This prospective observational study was conducted on 100 singleton pregnant women with gestational age >28 weeks attending the antenatal clinic and labour room of Pt. B.D. Sharma PGIMS, Rohtak. Detailed history, clinical examination, and body mass index (BMI) assessment were performed. Lipid profiles were analyzed using auto-analyzers. Hyperlipidemia was defined as total cholesterol >200 mg/dL, triglycerides (TGs) ≥150 mg/dL, high-density lipoprotein (HDL-C)≤45 mg/dL, or low-density lipoprotein (LDL)≥130 mg/dL. Participants were followed until delivery and maternal and neonatal outcomes were recorded.
Results: Hyperlipidemia was observed in 98% of the study participants. Elevated TGs were seen in 86% and elevated LDL in 37%. Hypercholesterolemia was significantly associated with induction of labour (35.71%, p=0.024). Pre-eclampsia occurred in 22.45% cases, PROM in 21.43%, intrahepatic cholestasis of pregnancy (IHCP) in 8.16%, fetal growth restriction in 3.06% and gestational diabetes mellitus (GDM) in 1.02%. Low HDL levels were significantly associated with maternal anaemia (p=0.012) and elevated LDL levels with IHCP (p=0.049). Low birth weight was observed in 35% neonates and 26.53% required NICU admission, most commonly due to prematurity.
Conclusions: Maternal hyperlipidemia was associated with increased maternal complications such as pre-eclampsia, IHCP, and anaemia, as well as neonatal prematurity and NICU admissions. Monitoring lipid profiles during pregnancy may help identify women at risk of adverse fetomaternal outcomes.
Metrics
References
Malik D, Narayanasamy N, Pratyusha VA, Thakur J, Sinha N. Dietary Lipids and Health. In. Textbook of Nutritional Biochemistry. 2023;1193228. DOI: https://doi.org/10.1007/978-981-19-4150-4
Nordestgaard BG, Langsted A. Lipoprotein (a) and cardiovascular disease. Lancet. 2024;28:1255-64. DOI: https://doi.org/10.1016/S0140-6736(24)01308-4
Christopher BA, Pagidipati NJ. Clinical updates in women’s health care summary: evaluation and management of lipid disorders: primary and preventive care review. Obstet Gynecol. 2019;133(3):609. DOI: https://doi.org/10.1097/AOG.0000000000003139
Herrera E. Lipid metabolism in pregnancy and its consequences in the fetus and newborn. Endocrine. 2002,19(1):1-43. DOI: https://doi.org/10.1385/ENDO:19:1:43
Festus OO, Idonije OB, Eseigbe MA, Okhiai O, Unuabonah F, Dike M. Comparative study of lipid profile of normal pregnant women in the different trimesters. Arch Appl Sci Res. 2011;3:528-32.
Jin WY, Lin SL, Hou RL. Associations between maternal lipid profile and pregnancy complications and perinatal outcomes: a population-based study from China. BMC Pregnancy Childbirth. 2016;16:1-9. DOI: https://doi.org/10.1186/s12884-016-0852-9
Hollingsworth DR, Grundy SM. Pregnancy-associated hypertriglyceridemia in normal and diabetic women: Differences in insulin-dependent, non-insulin-dependent, and gestational diabetes. Diabetes. 1982;1:1092-97. DOI: https://doi.org/10.2337/diacare.31.12.1092
Andraweera PH, Condon B, Collett G, Gentilcore S, Lassi ZS. Cardiovascular risk factors in those born preterm-systematic review and meta-analysis. J Developmental Origins Health Dis. 2021;12:539-54. DOI: https://doi.org/10.1017/S2040174420000914
Apgar V. A proposal for a new method of evaluation of the newborn infant. Anesth Analg. 1953;1(32):260-7. DOI: https://doi.org/10.1213/00000539-195301000-00041
Tranquilli A, Dekker G, Magee L. The classification, diagnosis and management of the hypertensive disorders of pregnancy: a revised statement from the ISSHP. Pregnancy Hypertens. 2014;4(2):97-104. DOI: https://doi.org/10.1016/j.preghy.2014.02.001
Lang T, McKeown G, Hunter A. Biochemical investigation and clinical management of obstetric cholestasis (OC): how useful is bile acid quantification? Arch Dis Child, Fetal Neonatal Edition. 2012;1:50-1. DOI: https://doi.org/10.1136/fetalneonatal-2012-301809.161
Melamed N, Klinger G, Tenenbaum-Gavish K. Short-term neonatal outcome in low-risk, spontaneous, singleton, late preterm deliveries. Obstet Gynecol. 2009;1:253-60. DOI: https://doi.org/10.1097/AOG.0b013e3181af6931
Gulati D, Mohi MK, Singh J, Kaur N, Singh B. Evaluation of Maternal Lipid Profile in Pregnancy and its feto-maternal outcome. J Cardiovascular Dis Res. 2022;13(7)546-56.
Singh A, Kujur A, Jain P. Feto-maternal impact of altered lipid profile in pregnancy. Int J Reprod Contracept Obstet Gynecol. 2017;7(1):132-6. DOI: https://doi.org/10.18203/2320-1770.ijrcog20175547
Kumari P, Chouhan M, Jakhar B, Sharma G. A comparative study of serum lipid profile in preeclampsia and normotensive pregnancy in third trimester and their fetomaternal outcome. Int J Reprod Contracept Obstet Gynecol. 2023;12(7):2177-84. DOI: https://doi.org/10.18203/2320-1770.ijrcog20231790
Parveen S, Zaman I, Noor N, Moin S, Ali SM. Maternal lipid profile and its impact on pregnancy outcome. J.South Asian Fed. Obstet. Gynecol. 2022;27:302-06. DOI: https://doi.org/10.5005/jp-journals-10006-2051
Sharami SH, Ranjbar ZA, Alizadeh F, Kazemnejad E. The relationship of hyperlipidemia with maternal and neonatal outcomes in pregnancy: A cross-sectional study. Int J of Reprod Biomed. 2019;17(10):739. DOI: https://doi.org/10.18502/ijrm.v17i10.5294
Dash S, Tiwari M, Dash P, Kar K, Mohakud NK. Complications of hypertriglyceridemia in pregnancy and its impact on neonates: a hospital-based study from Odisha. Cureus. 2022;14(8):e28399. DOI: https://doi.org/10.7759/cureus.28399
Downloads
Published
How to Cite
Issue
Section
